Meta Platforms, Inc. is downgraded to a Hold rating given fair valuation and capped upside. Learn more about META stock here.
The company raised full-year 2025 revenue guidance to at least $33 million, including at least 27 Growth Direct System placements. Management expects the recent multi-system order to meaningfully ...
The company reported double-digit gains across all regions, led by Asia and Europe, and a 13% increase in North America.
Biotechnology company Moderna (NASDAQ:MRNA) reported in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On ...
The signs were there but subtle. Dustin Chandler never did his homework. He was labeled lazy at school. It wasn’t until years later when his mother, now working at a pediatric clinic, watched him ...